For example, in melanoma, RASSF6 suppresses MAPK activation [17]; whether RASSF6 also inhibits MAPK signalling in CRC, and whether Wnt is the primary mechanism that mediates the regulation of RASSF6 in CRC remains to be determined. Here, RASSF6 is linked to melanoma.